Search results
Prometheus Bio 'Comfortably Overshoots' Drug's Expectations — And Shares Nearly Triple
Investor's Business Daily· 1 year agoPrometheus Biosciences reported promising results for one of its drugs in two inflammatory disease...
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
Investor's Business Daily· 1 year agoMerck is acquiring immunology-focused drugmaker Prometheus Bio in a well-timed $10.8 billion deal...
Dow Jones Futures Rise: Big News For Merck; Tesla, Apple Lead 7 Stocks Near Buy Points
Investor's Business Daily· 1 year agoDow Jones futures edged higher Monday morning, along with S&P 500 futures. Nasdaq futures tilted...
Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck
Zacks via Yahoo Finance· 1 year agoPrometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product...
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature...
Why Shares of Prometheus Biosciences Are Soaring This Week
Motley Fool· 1 year agoWhat happened Prometheus Biosciences (NASDAQ: RXDX) saw its shares rise this week as much as 168.7%...
Is Prometheus Biosciences a Good Stock to Buy Right Now?
Motley Fool· 1 year agoShares of Prometheus Biosciences (NASDAQ: RXDX) nearly tripled on Wednesday, Dec. 7, 2022. Investors...
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome
Investor's Business Daily· 2 years agoIn recent days, biotech stocks have slowed their early-August sprint. Now, the industry group is...
Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review
Investor's Business Daily· 1 year agoThe stock market rally continued to move sideways, with the major indexes trading tightly, between...
TipRanks ‘Perfect 10’ List: These 2 Healthcare Stocks Look Compelling at Current Levels
TipRanks via Yahoo Finance· 1 year agoWith two full months of 2023 behind us, it’s hard to say just how this year is going to shape up....